{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:47:05Z","timestamp":1782398825132,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00595-026-03235-x","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:54:03Z","timestamp":1768902843000},"page":"1236-1244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upfront surgery for clinical N1 stage II non-small cell lung cancer"],"prefix":"10.1007","volume":"56","author":[{"given":"Yukio","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideomi","family":"Ichinokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritoshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takamochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"3235_CR1","doi-asserted-by":"publisher","first-page":"eS278","DOI":"10.1378\/chest.12-2359","volume":"143","author":"JA Howington","year":"2013","unstructured":"Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143:eS278\u2013313.","journal-title":"Chest"},{"key":"3235_CR2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkisteet J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv1\u201321.","journal-title":"Ann Oncol"},{"key":"3235_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.athoracsur.2016.05.065","volume":"102","author":"PJ Speicher","year":"2016","unstructured":"Speicher PJ, Fitch ZW, Gulack BC, Yang CJ, Tong BC, Harpole DH, et al. Induction chemotherapy is not superior to a Surgery-First strategy for clinical N1 Non-Small cell lung cancer. Ann Thorac Surg. 2016;102:884\u201394.","journal-title":"Ann Thorac Surg"},{"key":"3235_CR4","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med. 2022;386:1973\u201385.","journal-title":"N Engl J Med"},{"key":"3235_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","volume":"389","author":"H Wakelee","year":"2023","unstructured":"Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, et al. Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer. N Engl J Med. 2023;389:491\u2013503.","journal-title":"N Engl J Med"},{"key":"3235_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/jcm14030988","volume":"14","author":"J Noy","year":"2025","unstructured":"Noy J, Chang A, Chow NP, Fernandez J, Dureja DJ, Cotamo R. Outcomes of resectable locally advanced Non-Small cell lung cancer after neoadjuvant chemoimmunotherapy: a single institution experience. J Clin Med. 2025;14:988.","journal-title":"J Clin Med"},{"key":"3235_CR7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00595-024-02812-2","volume":"54","author":"E Goto","year":"2024","unstructured":"Goto E, Hattori A, Fukui M, Matsunaga T, Takamochi K, Suzuki K. Salvage extended surgery after immune-chekpoint inhibitor treatment for advanced non-small cell lung cancer. Surg Today. 2024;54:917\u201326.","journal-title":"Surg Today"},{"key":"3235_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(13)62159-5","volume":"383","author":"Preoperative chemotherapy for","year":"2014","unstructured":"Preoperative chemotherapy for. non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet. 2014;383:1561\u201371.","journal-title":"Lancet"},{"key":"3235_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/JTO.0b013e3181a0d82e","volume":"4","author":"VW Rusch","year":"2009","unstructured":"Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Peter G, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4:568\u201377.","journal-title":"J Thorac Oncol"},{"key":"3235_CR10","volume-title":"WHO Classification of Tumours: Thoracic Tumours","author":"WHO Classification of Tumors Editorial Board","year":"2021","unstructured":"WHO Classification of Tumors Editorial Board. WHO Classification of Tumours: Thoracic Tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2021.","edition":"5th ed"},{"key":"3235_CR11","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.athoracsur.2004.11.025","volume":"79","author":"S Watanabe","year":"2005","unstructured":"Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. Ann Thorac Surg. 2005;79:1682\u20135.","journal-title":"Ann Thorac Surg"},{"key":"3235_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/thx.2006.062760","volume":"63","author":"T Hishida","year":"2008","unstructured":"Hishida T, Yoshida J, Nishimura M, Nishiwaki Y, Nagai K. Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer. Thorax. 2008;63:526\u201331.","journal-title":"Thorax"},{"key":"3235_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00595-008-4072-4","volume":"40","author":"K Miyoshi","year":"2010","unstructured":"Miyoshi K, Mimura T, Iwanaga K, Adachi S, Tsubota N, Okada M. Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis. Surg Today. 2010;40:428\u201332.","journal-title":"Surg Today"},{"key":"3235_CR14","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/jjco\/hyv129","volume":"45","author":"J Samejima","year":"2015","unstructured":"Samejima J, Nakao M, Matsuura Y, Uehara H, Mun M, Nakagawa K, et al. Prognostic impact of bulky swollen lymph nodes in cN1 non-small cell lung cancer patients. Jpn J Clin Oncol. 2015;45:1050\u20134.","journal-title":"Jpn J Clin Oncol"},{"key":"3235_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11748-019-01205-4","volume":"68","author":"M Tamura","year":"2020","unstructured":"Tamura M, Matsumoto I, Tanaka Y, Saito D, Yoshida S, Takata M, et al. Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2020;68:261\u20135.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"3235_CR16","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1097\/JTO.0b013e3181ec7e70","volume":"5","author":"M Nakao","year":"2010","unstructured":"Nakao M, Yoshida J, Ishii G, Kawase A, Maeda R, Aokage K, et al. Prognostic impact of node involvement pattern in pN1 non-small cell lung cancer patients. J Thorac Oncol. 2010;5:1576\u201382.","journal-title":"J Thorac Oncol"},{"key":"3235_CR17","doi-asserted-by":"publisher","DOI":"10.70352\/scrj.cr.24-0069","author":"A Asakawa","year":"2025","unstructured":"Asakawa A, Ishizawa R, Sato Y, Ishikawa Y, Wakejima R, Ishibashi H, et al. A case of induction chemoimmunotherapy and sleeve lobectomy to avoid pneumonectomy for central squamous cell lung cancer. Surg Case Rep. 2025;11:24-0069. https:\/\/doi.org\/10.70352\/scrj.cr.24-0069.","journal-title":"Surg Case Rep"},{"key":"3235_CR18","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1200\/JCO.22.02186","volume":"41","author":"RS Herbst","year":"2023","unstructured":"Herbst RS, Wu YL, John T, Grohe C, Majem M, Wang J, et al. Adjuvant osimertinib for resected EGFR-Mutated stage IB-IIIA Non-Small-Cell lung cancer: updated results from the phase III randomized ADAURA trial. J Clin Oncol. 2023;41:1830\u201340.","journal-title":"J Clin Oncol"},{"key":"3235_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJMoa2304594","volume":"389","author":"M Tsuboi","year":"2023","unstructured":"Tsuboi M, Herbst RS, John T, Kato T, Majem M, Groh\u00e9 C, et al. Overall survival with osimertinib in resected EGFR-mutated NSCLC. N Engl J Med. 2023;389:137\u201347.","journal-title":"N Engl J Med"},{"key":"3235_CR20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","volume":"19","author":"R Rami-Porta","year":"2024","unstructured":"Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2024;19:1007\u201327.","journal-title":"J Thorac Oncol"},{"key":"3235_CR21","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1056\/NEJMoa043623","volume":"352","author":"T Winton","year":"2005","unstructured":"Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med. 2005;352:2589\u201397.","journal-title":"N Engl J Med"},{"key":"3235_CR22","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","volume":"26","author":"JP Pignon","year":"2008","unstructured":"Pignon JP, Tribodet H, Scagliotti GV, Rigas J, Johnston M, Butts C, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J Clin Oncol. 2008;26:3552\u20139.","journal-title":"J Clin Oncol"},{"key":"3235_CR23","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jtcvs.2016.01.058","volume":"151","author":"MJ Bott","year":"2016","unstructured":"Bott MJ, Patel AP, Verma V, Crabtree TD, Morgensztern D, Robinson CG, et al. Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity? J Thorac Cardiovasc Surg. 2016;151:1549\u201358.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3235_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa2502931","volume":"393","author":"PM Forde","year":"2025","unstructured":"Forde PM, Spicer JD, Provencio M, Mitsudomi T, Awad MM, Wang C, et al. Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer. N Engl J Med. 2025;393:741\u201352.","journal-title":"N Engl J Med"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03235-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03235-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03235-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:56:31Z","timestamp":1782395791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03235-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3235"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03235-x","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective review was performed with a waiver of authorization approved by the Institutional Review Board of the Juntendo University School of Medicine (IRB: E24-0283). The requirement for written informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}